In this lively discussion, Aaron Schmidt, head of Harvard's virology program, shares his insights on using protein engineering to modulate immune responses against viruses like influenza. Tatum Sass reflects on her CAR T cell advancements, while Ben Gewurz unpacks the complexities of Epstein-Barr virus and its ties to health issues. They emphasize resilience in research and the need for clear science communication, all set against the backdrop of the Harvard virology retreat, which celebrates collaboration and the importance of mentorship in shaping future scientists.
